Citigroup’s Guardian Pharmacy Services GRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$728K Buy
17,861
+2,346
+15% +$95.7K ﹤0.01% 3532
2026
Q2
$650K Buy
15,515
+12,180
+365% +$472K ﹤0.01% 3759
2026
Q1
$126K Sell
3,335
-8,342
-71% -$273K ﹤0.01% 4198
2025
Q4
$351K Buy
11,677
+9,257
+383% +$262K ﹤0.01% 3741
2025
Q3
$63.5K Sell
2,420
-3,034
-56% -$72.3K ﹤0.01% 4418
2025
Q2
$116K Sell
5,454
-572
-9% -$12.9K ﹤0.01% 4336
2025
Q1
$128K Sell
6,026
-711
-11% -$14.6K ﹤0.01% 4456
2024
Q4
$136K Buy
+6,737
New +$139K ﹤0.01% 4673

Other funds holding GRDN

Citigroup's GRDN Position: Q3 2026 in Review

Citigroup increased its Guardian Pharmacy Services (GRDN) stake by 15% in Q3 2026, buying an estimated $95.7K and bringing the position to 17,861 shares worth $728K. The position accounts for ﹤0.01% of the portfolio, ranked #3532.

Citigroup first reported a position in GRDN in Q4 2024 and has held it in 8 quarters since. 44 funds tracked by Wall St. Rank hold GRDN as of Q3 2026.

  • Citigroup held 17,861 shares of Guardian Pharmacy Services worth $728K as of Q3 2026.
  • Citigroup bought 2,346 Guardian Pharmacy Services shares in Q3 2026, an estimated $95.7K.
  • Guardian Pharmacy Services made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #3532 holding.
  • Citigroup first reported a position in Guardian Pharmacy Services in Q4 2024 and has held it in 8 quarters since.
  • 44 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.